Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice
- PMID: 31277150
- PMCID: PMC6635248
- DOI: 10.1097/MD.0000000000016270
Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice
Abstract
Ultrasound is routinely used during the evaluation of liver cirrhosis. Inter-observer variability is considered a major drawback. This retrospective study investigated the accuracy of ultrasound in diagnosing compensated cirrhosis (i.e., modified Knodell F3, F4) in chronic hepatitis C (CHC) patients in real world clinical practice. Consecutive treatment-naive CHC patients who underwent liver biopsy (LB) prior to interferon therapy from 1997 to 2010 were enrolled. Ultrasound was performed by 30 hepatologists prior to LB. Ultrasound-identified cirrhosis was defined as small liver size, nodular liver surface and coarse liver parenchyma. LB was used as a reference, and the diagnostic accuracy of ultrasound was assessed and compared. Fibrosis was scored according to the modified Knodell classification. A cohort comprising 1738 patients, including 922 men and 816 women with a mean age of 52.5 years, was analyzed in the present study. The distribution of the patients' modified Knodell scores was F0 = 336, F1 = 489, F2 = 165, F3 = 315, F4 = 433. Ultrasound-identified cirrhosis was noted in 283 patients. Using ultrasound-identified cirrhosis to predict compensated cirrhosis, the sensitivity was 34.0%, the specificity was 97.1%, the positive predictive value was 89.8%, the negative predictive value was 66.1%, the positive likelihood ratio was 11.6, and the negative likelihood ratio was 0.68. The area under the ROC curve (AUROC) was 0.66.Despite being affected by inter-observer variability, ultrasound is highly specific in diagnosing compensated cirrhosis in CHC patients in real world clinical practice. However, the sensitivity is low.
Conflict of interest statement
The authors have no conflicts of interest relevant to this article.
Figures



Similar articles
-
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study.Hepatology. 2012 Dec;56(6):2125-33. doi: 10.1002/hep.25936. Epub 2012 Aug 31. Hepatology. 2012. PMID: 22767302
-
The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.Eur J Gastroenterol Hepatol. 2015 Aug;27(8):895-900. doi: 10.1097/MEG.0000000000000379. Eur J Gastroenterol Hepatol. 2015. PMID: 25951491
-
AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C.Turk J Gastroenterol. 2011 Jun;22(3):279-85. doi: 10.4318/tjg.2011.0213. Turk J Gastroenterol. 2011. PMID: 21805418
-
Non-invasive evaluation of liver fibrosis in chronic hepatitis C.Rev Med Chir Soc Med Nat Iasi. 2012 Jan-Mar;116(1):135-8. Rev Med Chir Soc Med Nat Iasi. 2012. PMID: 23077885 Review.
-
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update.BMJ Open. 2019 Nov 11;9(11):e027491. doi: 10.1136/bmjopen-2018-027491. BMJ Open. 2019. PMID: 31719068 Free PMC article.
Cited by
-
Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance.Int J Mol Sci. 2024 Jan 18;25(2):1198. doi: 10.3390/ijms25021198. Int J Mol Sci. 2024. PMID: 38256273 Free PMC article.
-
Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy.J Clin Med. 2021 Apr 11;10(8):1621. doi: 10.3390/jcm10081621. J Clin Med. 2021. PMID: 33920491 Free PMC article.
-
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C.World J Hepatol. 2023 Dec 27;15(12):1315-1324. doi: 10.4254/wjh.v15.i12.1315. World J Hepatol. 2023. PMID: 38223417 Free PMC article.
-
Awareness of hepatitis C prevention and treatment and high-risk behaviors among the general population in Anhui Province: a cross-sectional study.Front Public Health. 2025 Mar 12;13:1534169. doi: 10.3389/fpubh.2025.1534169. eCollection 2025. Front Public Health. 2025. PMID: 40144995 Free PMC article.
-
Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection-Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male Patients.Int J Mol Sci. 2023 May 7;24(9):8402. doi: 10.3390/ijms24098402. Int J Mol Sci. 2023. PMID: 37176109 Free PMC article.
References
-
- Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2:161–76. - PubMed
-
- European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol Hepatol 2017;2:325–36. - PubMed
-
- European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol 2018;69:461–511. - PubMed
-
- European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237–64. - PubMed
-
- de Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:743–52. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous